Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) in patients (pts) with impaired renal function.

被引：0
|
作者：
Koshkin, Vadim S.
Barata, Pedro C.
Zahoor, Haris
Rybicki, Lisa A.
Almassi, Nima
Redden, Alicia M.
Fergany, Amr Farouk
Kaouk, Jihad
Haber, Georges-Pascal
Stephenson, Andrew J.
Martin, Allison
Allman, Kimberly D.
Beach, Jennifer
Ornstein, Moshe Chaim
Gilligan, Timothy D.
Garcia, Jorge A.
Rini, Brian I.
Grivas, Petros
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[2] Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.446
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
446
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
    Koshkin, Vadim S.
    Barata, Pedro C.
    Rybicki, Lisa A.
    Zahoor, Haris
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr F.
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Garcia, Jorge A.
    Rini, Brian, I
    Grivas, Petros
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E879 - E892
  • [2] Cisplatin-based neoadjuvant chemotherapy (NAC) in bladder cancer patients (Pts) with borderline renal function: Implications for clinical practice.
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zahoor, Haris
    Rybicki, Lisa A.
    Emamekhoo, Hamid
    Almassi, Nima
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery
    Chanza, Nieves Martinez
    Hamid, Anis
    Salgado, Roberto
    Gevaert, Thomas
    Maetens, Marion
    Rorive, Sandrine
    Aftimos, Philippe Georges
    Sideris, Spyridon
    Gil, Thierry
    Awada, Ahmad
    Roumeguere, Thierry Andre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).
    Tsironis, George
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Tzanis, Kimon
    Varkarakis, John
    Papatsoris, Athanasios
    Stravodimos, Kostas
    Kostouros, Efthymios
    Fragkoulis, Charalampos
    Choreftaki, Theodosia
    Filippiadis, Dimitrios
    Fontara, Sofia
    Dellis, Athanasios
    Ntai, Sparti
    Zygogianni, Anna
    Ntoumas, Konstantinos
    Constantinides, Constantinos A.
    Korkolopoulou, Penelope
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Plasticity in muscle-invasive bladder cancer before and after cisplatin-based neoadjuvant chemotherapy
    Seiler, Roland
    Gibb, Ewan A.
    Takhar, Mandeep
    Van Kessel, Kim
    van Rhijn, Bas W. G.
    Winters, Brian
    Douglas, James
    Wang, Qiqi
    Choeurng, Voleak
    Erho, Nicholas
    Buerki, Christine
    Davicioni, Elai
    Sjodahl, Gottfrid
    Thalmann, George N.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Dall'Era, Marc
    van der Heijden, Michiel S.
    Wright, Jonathan
    Black, Peter C.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 618 - 618
  • [6] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Philip H. Kim
    Matthew Kent
    Philip Zhao
    John P. Sfakianos
    Dean F. Bajorin
    Bernard H. Bochner
    Guido Dalbagni
    [J]. World Journal of Urology, 2014, 32 : 453 - 459
  • [7] The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Kim, Philip H.
    Kent, Matthew
    Zhao, Philip
    Sfakianos, John P.
    Bajorin, Dean F.
    Bochner, Bernard H.
    Dalbagni, Guido
    [J]. WORLD JOURNAL OF UROLOGY, 2014, 32 (02) : 453 - 459
  • [8] The impact of neoadjuvant chemotherapy (NAC) on conditional survival (CS) among patients with muscle-invasive bladder cancer (MIBC).
    Waingankar, Nikhil
    Jia, Rachel
    Ferket, Bart
    Audenet, Francois
    Mehrazin, Reza
    Sfakianos, John
    Mazumdar, Madhu
    Galsky, Matt D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [9] Safety and efficacy of neoadjuvant chemotherapy (NAC) with accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (aMVAC) in patients (pts) with muscle invasive bladder cancer (MIBC) as a function of age
    Zibelman, Matthew R.
    Lewis, Bianca
    Ross, Eric A.
    Anari, Fern
    Ghatalia, Pooja
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [10] Efficacy of split schedule (SS) vs conventional schedule (CS) neoadjuvant cisplatin-based chemotherapy for muscle-invasive bladder cancer (MIBC)
    Osterman, Chelsea K.
    Babu, Dilip Sankar
    Geynisman, Daniel M.
    Lewis, Bianca
    Somer, Robert A.
    Balar, Arjun Vasant
    Zibelman, Matthew R.
    Guancial, Elizabeth A.
    Narayan, Vivek
    Guzzo, Thomas J.
    Plimack, Elizabeth R.
    Vaughn, David J.
    Fung, Chunkit
    Mamtani, Ronac
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345